BCM
TENX icon

Bridgeway Capital Management’s Tenax Therapeutics TENX Stock Holding History

Bridgeway Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Buy
59,900
+15,000
+33% +$192K 0.02% 764
2026
Q1 		$718K Hold
44,900
– – 0.01% 765
2025
Q4 		$547K Buy
+44,900
New +$391K 0.01% 805

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Bridgeway Capital Management's TENX Position: Q2 2026 in Review

Bridgeway Capital Management increased its Tenax Therapeutics (TENX) stake by 33% in Q2 2026, buying an estimated $192K and bringing the position to 59,900 shares worth $872K. The position accounts for 0.02% of the portfolio, ranked #764.

Bridgeway Capital Management first reported a position in TENX in Q4 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Bridgeway Capital Management held 59,900 shares of Tenax Therapeutics worth $872K as of Q2 2026.
  • Bridgeway Capital Management bought 15,000 Tenax Therapeutics shares in Q2 2026, an estimated $192K.
  • Tenax Therapeutics made up 0.02% of Bridgeway Capital Management's portfolio in Q2 2026, its #764 holding.
  • Bridgeway Capital Management first reported a position in Tenax Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.